NFL ends E.D. drug sponsorship

Share this article:
The NFL decided not to renew its sponsorship agreement with Levitra, which is co-marketed in the U.S. by Schering-Plough and GlaxoSmithKline. The league says it will not seek a replacement in the category, according to published reports. The NFL based its decision on the tone of ads for erectile dysfunction drugs. Over the past three years advertising has ranged in focus from men’s health to men’s performance and lifestyle. Ads by Levitra and others have recently been more restrained, however, not mentioning a product name but describing conditions the drug could help treat.
Share this article:

Email Newsletters

More in Business Briefs

Researchers hit links for charity

The PMR Charities Golf Classic teed up more than $20,000 for St. Jude Children's Research Hospital.

FDA to review Neupogen biosimilar

Novartis subsidiary Sandoz announced Thursday that the FDA has agreed to review its filgrastim biosimilar which is already approved in 40 countries.

FDA approves a new painkiller

Targiniq ER combines the prescription opioid oxycodone and naloxone, which is often used to treat overdoses.